Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
about
The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25Insights into Regulation of the miR-17-92 Cluster of miRNAs in CancerSignificance and therapeutic value of miRNAs in embryonal neural tumorsSmall molecule compounds targeting miRNAs for cancer therapyncRNA-regulated immune response and its role in inflammatory lung diseasesMicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknownTherapeutic use of microRNAs in lung cancerMicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development.MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancerMicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathwayDifferential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis.Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancerInhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure OverloadMicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinomaRole of MYC in Medulloblastoma.Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases.microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network.MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyTargeted treatment for sonic hedgehog-dependent medulloblastoma.Antitumor mechanisms when pRb and p53 are genetically inactivated.The biomarker and therapeutic potential of miRNA in Alzheimer's disease.General hallmarks of microRNAs in brain evolution and developmentmiRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy.Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma.miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.
P2860
Q26748969-C78F522B-3A31-428A-A88E-4874FBBAAF0FQ26781049-FC24263D-04E3-47DD-9756-5A5283BD8052Q26827171-616F0343-B6C0-423E-90BE-75F3A8B11645Q26829982-F59C17D8-B3A4-4B78-82CC-379A30208427Q28082698-C519A3B3-36F7-452B-844A-F5CA32074DAFQ28083277-A03821A7-922A-462F-8334-5FEA3F062BB7Q28395179-42E0F007-7C7D-4066-9C00-E6BEDA05CF9FQ33829355-393C771E-8CEF-486D-A32C-3AB4D9737BFAQ34131951-0DBFB803-91EC-4FF6-9B7B-A0F3CE6CCB34Q34501935-0C250EC6-3F95-4EAA-A8DC-103D143EA455Q34544501-D6D89A26-D976-47A4-8F7F-A98D9EB2530CQ34685896-8014A488-C178-494E-A986-2C824F978664Q35108974-97DD0B9F-4871-426B-87C7-C5D14E18DC9DQ35145398-E2EA8E31-E5AC-473E-85CB-EA4542AC56D2Q35154495-8957C859-9467-45EB-ACD9-D2F7099D7852Q35163626-AB212282-99A5-404B-B99F-B44E3B31B31EQ35237068-9017409E-19F2-4D68-86D2-FAB5E4F24211Q35668665-C96DEEA7-85D1-4D9B-AAB8-158F1684E0A6Q35813690-8E5592A6-AA0F-4A73-ABE0-343C16B18C95Q36033063-1E6F9675-43FA-48ED-800B-E4A5F1258650Q36051089-3B4C2C0B-FD39-48E0-A436-87371C32CE2AQ36290193-C9D700B2-5554-48DA-B9EF-DA2F3C5B6CC4Q36536455-75736B25-2043-45B0-B79D-E7686189180CQ36634367-037C7CFF-AE84-46BA-8FA6-41CFCEAE19F4Q37143955-5F975F3F-DB78-411D-8588-0D1F1B195B60Q37256443-0A2925AE-7B4E-483D-A41D-9FB33286AA14Q37601935-192C96C5-DCFC-4A98-ADDA-689DDD7C8B9CQ37644050-853D8274-E991-4E14-A715-65487EF0289BQ37738099-2AE90A09-AFDB-4BBB-B059-6538F8321E25Q38172970-30DA23F7-A636-45D7-880C-8C88346949F3Q38222028-05DC5B3D-B5F6-4D9F-8759-ACA9DCF69060Q38285170-5ACB432E-28A7-4881-9124-072870A7FC82Q38364827-25161CB9-5B08-47BC-9D1A-5DE23673739FQ38497857-D082C759-AF2D-4007-9C4E-0A6FFA58DA3BQ38591803-1410859B-B0A1-4E5A-96B2-09F4C47638D2Q38744898-A9F1B142-54CB-4774-BBD1-08E110C7C0A3Q38768383-6B6598E4-4490-48CA-A7A1-518CE2C14EC4Q38850586-E58132E5-49E5-4ABA-BC24-E2E145B6F449Q38928155-649C2DE3-2465-4EED-8EE3-B7F9748F2050Q38973879-FA889358-2ADE-4B36-8ED9-F82D794BE536
P2860
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@en
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@nl
type
label
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@en
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@nl
prefLabel
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@en
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@nl
P2093
P2860
P1433
P1476
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
@en
P2093
Brian L Murphy
Frederique Zindy
Laure Bihannic
Olivier Ayrault
Sakari Kauppinen
Susanna Obad
P2860
P304
P356
10.1158/0008-5472.CAN-13-0927
P407
P577
2013-10-21T00:00:00Z